Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PlanetRx.com Calls For On-Line Pharmacy Industry "Summit"

Executive Summary

The online pharmacy industry should convene a "summit" of industry and technology leaders to establish a monitoring system for suspected rogue sites, PlanetRx.com CEO William Razzouk suggested at a July 30 House Commerce/Oversight & Investigations Subcommittee hearing on "Drugstores on the Net."

You may also be interested in...



PlanetRx.com To Receive Electronic Rx Transmissions Under AHT Contract

PlanetRx.com's prescription management agreement with Internet technology firm AHT Corporation will soon allow healthcare providers to write and transmit prescriptions electronically to the PlanetRx.com website, the online pharmacy announced in its third quarter earnings report.

PlanetRx.com To Receive Electronic Rx Transmissions Under AHT Contract

PlanetRx.com's prescription management agreement with Internet technology firm AHT Corporation will soon allow healthcare providers to write and transmit prescriptions electronically to the PlanetRx.com website, the online pharmacy announced in its third quarter earnings report.

Express Scripts Offers Access To Lives, Not Cash, For 20% Of PlanetRx.com

Express Scripts is acquiring 19.9% of the online pharmacy PlanetRx.com in exchange for access to the PBM's customer base and third-party contracts. Express Scripts is not using cash or stock to pay for its investment in PlanetRx.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS034652

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel